fren

Dean A. Fergusson, MHA, PhD, Senior Scientist & Director, Clinical Epidemiology Program, Ottawa Hospital Research Institute; Full Professor, Departments of Medicine, Surgery, & School of Epidemiology and Public Health, University of Ottawa; OHRI/uOttawa Clinical Epidemiology Program Endowed Chair

Dean Fergusson, PhD is a Senior Scientist and Director of the Clinical Epidemiology Program (CEP) at the Ottawa Hospital Research Institute and a Full Professor in the Department of Medicine with cross-appointments to the School of Epidemiology & Public Health and the Department of Surgery at the University of Ottawa. His two areas of research scholarship are: 1) transfusion medicine and transfusion alternatives; and 2) innovative methodological research into the design and analysis of clinical trials. His methodological work in clinical trials includes the areas of clinical equipoise, innovative pragmatic trials, patient and public engagement, post-randomization exclusions, ethical use of placebo controls, and statistical approaches. He has served or chaired CIHR panels (RCT, New Investigator, Mentoring) and is an active member on editorial boards (Transfusion Medicine Reviews, Transfusion Medicine, Clinical Trials, Trials). He has also been an active member of renowned disease clinical trial networks in transfusion, critical care, and thrombosis.